Citius Oncology Statistics
Total Valuation
CTOR has a market cap or net worth of $90.87 million. The enterprise value is $94.67 million.
Important Dates
The next estimated earnings date is Friday, February 21, 2025, before market open.
Earnings Date | Feb 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CTOR has 71.55 million shares outstanding. The number of shares has increased by 0.82% in one year.
Current Share Class | 71.55M |
Shares Outstanding | 71.55M |
Shares Change (YoY) | +0.82% |
Shares Change (QoQ) | +3.28% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.05% |
Float | 5.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.97 |
P/TBV Ratio | 1.97 |
P/FCF Ratio | 719.19 |
P/OCF Ratio | 719.19 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 749.26 |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.08.
Current Ratio | 0.34 |
Quick Ratio | n/a |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | 30.08 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.01% and return on invested capital (ROIC) is -34.07%.
Return on Equity (ROE) | -59.01% |
Return on Assets (ROA) | -19.47% |
Return on Capital (ROIC) | -34.07% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CTOR has paid $576,000 in taxes.
Income Tax | 576,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.38% in the last 52 weeks. The beta is -0.64, so CTOR's price volatility has been lower than the market average.
Beta (5Y) | -0.64 |
52-Week Price Change | -88.38% |
50-Day Moving Average | 1.14 |
200-Day Moving Average | 6.71 |
Relative Strength Index (RSI) | 54.07 |
Average Volume (20 Days) | 170,975 |
Short Selling Information
The latest short interest is 84,449, so 0.12% of the outstanding shares have been sold short.
Short Interest | 84,449 |
Short Previous Month | 77,332 |
Short % of Shares Out | 0.12% |
Short % of Float | 1.53% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -20.57M |
Pretax Income | n/a |
Net Income | -21.15M |
EBITDA | n/a |
EBIT | -20.57M |
Earnings Per Share (EPS) | -$0.31 |
Full Income Statement Balance Sheet
The company has $112 in cash and $3.80 million in debt, giving a net cash position of -$3.80 million or -$0.05 per share.
Cash & Cash Equivalents | 112 |
Total Debt | 3.80M |
Net Cash | -3.80M |
Net Cash Per Share | -$0.05 |
Equity (Book Value) | 46.14M |
Book Value Per Share | 0.64 |
Working Capital | -21.73M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 126,353 |
Capital Expenditures | n/a |
Free Cash Flow | 126,353 |
FCF Per Share | $0.00 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |